Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07289217Not ApplicableNot Yet Recruiting

WELT-REST: WELT Randomized Evaluation of Sleep Therapy

Role: lead

NCT06695000Not ApplicableNot Yet Recruiting

Digital CBT-I for Chronic Insomnia

Role: lead

NCT06294353Not ApplicableRecruiting

Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01)

Role: lead

NCT05822999Not ApplicableCompleted

Study of Efficacy of WELT-IP in Insomnia (WCTP-I-B-01)

Role: lead

NCT05809544Not ApplicableCompleted

Study of Efficacy of WELT-IP in Insomnia (WCTP-I-B-02)

Role: lead

All 5 trials loaded